{"@id":"https://bioecon.ru/technology/autologous-tumor-lysate-vaccine/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/autologous-tumor-lysate-vaccine/","json":"https://cn.bioecon.ru/api/v1/technology/autologous-tumor-lysate-vaccine/index.json"},"id":"autologous-tumor-lysate-vaccine","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/botanical-solution-inc/","https://bioecon.ru/companies/medtronic/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/gsk/"]},"maturity":7,"name":"自体全肿瘤细胞裂解物抗原特异性治疗性疫苗","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"手术样本无菌获取与单细胞悬液解离"},{"n":2,"title":"程序化冻融与致死剂量伽马射线灭活"},{"n":3,"title":"临床级复合免疫佐剂标准化配制"},{"n":4,"title":"皮内多点阶梯接种与抗肿瘤免疫监视"}],"summary":"以手术切除的患者自体新鲜原发肿瘤组织为来源，经程序冻融与射线辐射灭活破碎制备全谱抗原裂解物，复合重组干扰素-γ或角鲨烯纳米佐剂，完整呈现个体多克隆新抗原库以终结术后复发。","url":"/technology/autologous-tumor-lysate-vaccine/","verified":"2026-11-22"}